Ionis Pharmaceuticals Inc (IONS)
38.00
+0.63
(+1.69%)
USD |
NASDAQ |
May 22, 16:00
38.00
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2012 | 3.476M |
| June 30, 2012 | 1.558M |
| March 31, 2012 | 1.379M |
| December 31, 2011 | |
| September 30, 2011 | 1.858M |
| June 30, 2011 | 5.674M |
| March 31, 2011 | 0.591M |
| December 31, 2010 | 1.242M |
| September 30, 2010 | 1.341M |
| June 30, 2010 | 5.04M |
| March 31, 2010 | 1.904M |
| December 31, 2009 | 10.90M |
| September 30, 2009 | 0.586M |
| June 30, 2009 | 0.783M |
| March 31, 2009 | 2.351M |
| December 31, 2008 | 4.121M |
| September 30, 2008 | 5.021M |
| June 30, 2008 | 6.399M |
| March 31, 2008 | 4.358M |
| December 31, 2007 | 6.177M |
| September 30, 2007 | 9.237M |
| June 30, 2007 | 2.296M |
| March 31, 2007 | 2.057M |
| December 31, 2006 | 2.395M |
| September 30, 2006 | 2.959M |
| Date | Value |
|---|---|
| June 30, 2006 | |
| March 31, 2006 | 3.503M |
| December 31, 2005 | 3.918M |
| September 30, 2005 | |
| June 30, 2005 | 4.456M |
| March 31, 2005 | 2.911M |
| December 31, 2004 | 10.05M |
| September 30, 2004 | 5.464M |
| June 30, 2004 | 9.593M |
| March 31, 2004 | 5.774M |
| December 31, 2003 | 2.657M |
| September 30, 2003 | 2.749M |
| June 30, 2003 | 2.725M |
| March 31, 2003 | 4.981M |
| December 31, 2002 | 14.91M |
| September 30, 2002 | |
| June 30, 2002 | |
| March 31, 2002 | |
| December 31, 2001 | |
| September 30, 2001 | 4.097M |
| June 30, 2001 | 2.098M |
| March 31, 2001 | 4.80M |
| December 31, 2000 | 3.346M |
| September 30, 2000 | 6.942M |
| June 30, 2000 | 4.644M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Biogen Inc | 2.000B |
| Viking Therapeutics Inc | -- |
| Madrigal Pharmaceuticals Inc | -- |
| Akero Therapeutics Inc | -- |
| 89bio Inc | -- |